Introduction
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is characterized by insulin oversecretion and severe hypoglycemia. The most common cause is inactivating mutations in ABCC8 gene, although mutations in other genes have also been described (1, 2) . Patients with ABCC8 gene mutations have severe neonatal forms and non-responders to medical treatment require pancreatectomy. Little is known of the longterm outcome of non-pancreatectomized patients (3) . The follow-up of 3 nonpancreatectomized patients is reported.
RESEARCH DESIGN AND METHODS
Three non-pancreatectomized male PHHI patients' non-responders to diazoxide with ABCC8 gene mutations, followed up from the neonatal period by us, were studied. Diagnosis in the neonatal period was based on: hypoglycemic episodes; high carbohydrate requirements (>15 mg/Kg/minute) to maintain normoglycemia; low plasma free fatty acid (<1500 mmol/L), low ketone body values (<2 mmol/L) and unsuppressed insulin levels (glucose (mg/dl)/insulin (mIU/mL) ratio <3) during hypoglycemia; glucagon (0.1mg/kg) response of hypoglycemic episodes (glycemia >50 mg/dl); and non-response to diazoxide (15 mg/Kg/day ) (failure to maintain glycemia >50 mg/dl with carbohydrate intake >15 mg/kg/minute) (3). ABCC8 gene study (39 exons and intronexon boundaries) showed: patient 1 2800C>T (R934X) (exon 23) and 3992-9G>A (intron 32), parents not evaluated; patient 2 3576delG (L1191LfsX1207) (exon 29, paternal) and 3751C>T (R1251X) (exon 30, maternal) and patient 3 3443T>G (L1148R) (exon 28, maternal) and 3751C>T (R1251X) (exon 30, paternal) (4).
Patients received continuous enteral nutrition during the neonatal period and the first three months of life, with the carbohydrate intake necessary to maintain glycemic values >50 mg/dl. From then until six months of age, intervals between daytime feeds were prolonged progressively up to every 3 hours and night-time continuous enteral nutrition was maintained until the age of 4-6 years, when a six times-daily intake was established and maintained thereafter.
Oral glucose tolerance test (OGTT) (5) and venous 24-hour glucose insulin profile (GIP) with samples drawn every 2 hours over a 24-hour period were performed.
Glucose, insulin (immunochemoluminescence), HOMA and QUICKI indexes (6), HbA1c (high molecular weight chromatography), anti-GAD65 autoantibodies (radioimmunoassay), islet cell antibodies (ICA) (indirect immunofluorescence), anti-IA2 antibodies (radioimmunoassay) and body mass index (BMI) values (7) were evaluated. 
RESULTS

Patients
CONCLUSIONS
A progressive improvement in severity and number of hypoglycemic episodes with age was observed. From the ages of 4 to 6, hypoglycemias were occasionally observed and capillary controls showed sporadic postprandial hyperglycemias (data not shown). The number and intensity of hyperglycemic episodes increased with age, and glucose metabolism impairment appeared with different progression among the patients. Patient 1 needed insulin at the age of 25 and patient 2, now 17, may need insulin by this age. However, in patient 3, now 24, only glucose intolerance has been observed. This evolution from a hyperinsulinemic state at birth to decreased insulin secretion later in life has also been reported in patients with ABCC8 (8, 9) and MODY-associated HNF4A gene mutations (10) . Type 1 diabetes-related autoantibodies were negative in our patients, suggesting that β-cell autoimmunity could be ruled out. HOMA and QUICKI within normal range (except the first evaluation of patient 2, not confirmed thereafter) and relatively low insulin values at 120 minutes suggested that insulin resistance may also be ruled out. BMI was also normal.
A higher rate of β-cell apoptosis than that of proliferation was observed in the pancreas of PHHI patients (11) . Furthermore, loss of insulin response to tolbutamide and blunted insulin response to intravenous dextrose were reported in PHHI non-diazoxideresponder patients treated medically or partially pancreatectomized, suggesting that lack of K-ATP channel activity may contribute to the late development of diabetes (12) . Additional studies including larger numbers of non-pancreatectomized patients are required to establish the natural history of this disease.
In summary, glucose metabolism impairment ranging from glucose intolerance to insulin-dependent diabetes is reported in three non-pancreatectomized PHHI patients, aged 17, 24 and 31, with mutations in the ABCC8 gene. 
